The IGF-IR/PI3K/Akt signaling pathway inhibited GSK3-activity by phosphorylation and this promoted -catenin nuclear localization. Our previous study indicated that -catenin mRNA level was significantly higher in tumor areas than in non-tumor ones, especially in late pathologic stage tumors. However, -catenin inhibition resulted in significantly suppressed migration and invasion ability of HA22T cells. Thus, Wnt/-catenin pathway over-activation might be involved in metastatic enhancement of apicidin-resistant HA22T cell metastasis. Apicidin-resistant (AR) HA22T cells showed higher -catenin nuclear accumulation and significantly decreased GSK-3-protein level, in relation to parental cells. Results also indicated that AR cells increased abundantly in Tbx3, a downstream target of Wnt/-catenin that it is implicated in liver cancer. AR cells also inhibited the MEK/ERK/PEA3 pathway which promoted MMP-2 activation. But, apicidin-resistant effect was totally reversed by LY294002 and AG1024. In conclusion, Apicidin-R HA22T cells activated the Wnt/-catenin pathway and induced, MMP-2 expression via IGF-IR/PI3K/Akt signaling further enhancing cell the metastatic effects.
The IGF-IR/PI3K/Akt signaling pathway inhibited GSK3-activity by phosphorylation and this promoted -catenin nuclear localization. Our previous study indicated that -catenin mRNA level was significantly higher in tumor areas than in non-tumor ones, especially in late pathologic stage tumors. However, -catenin inhibition resulted in significantly suppressed migration and invasion ability of HA22T cells. Thus, Wnt/-catenin pathway over-activation might be involved in metastatic enhancement of apicidin-resistant HA22T cell metastasis. Apicidin-resistant (AR) HA22T cells showed higher -catenin nuclear accumulation and significantly decreased GSK-3-protein level, in relation to parental cells. Results also indicated that AR cells increased abundantly in Tbx3, a downstream target of Wnt/-catenin that it is implicated in liver cancer. AR cells also inhibited the MEK/ERK/PEA3 pathway which promoted MMP-2 activation. But, apicidin-resistant effect was totally reversed by LY294002 and AG1024. In conclusion, Apicidin-R HA22T cells activated the Wnt/-catenin pathway and induced, MMP-2 expression via IGF-IR/PI3K/Akt signaling further enhancing cell the metastatic effects.
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Metastasis is a complex series of steps in which cancer cells leave the original tumor site and migrate to other parts of the body via the bloodstream or the lymphatic system. Cancer metastasis represents the most important cause of cancer death. Breakdown of the extracellular matrix (ECM) by proteinases is an essential step in the processes. Malignant progression is frequently associated with enhanced production or activity of one or several matrix metalloproteinases (MMP). 1) MMPs are a family of structurally related zinc-dependent endopeptidases capable of degrading ECM components. [2] [3] [4] A number of in vitro and in vivo studies have indicated a direct correlation between high levels of expression of MMP and enhanced invasive capacity of tumor cell lines.
1,5-7)
A 72-kDa type IV collagenase, MMP-2, is thought to play a crucial role in tumor cell invasion by facilitating the degradation of basement membrane type IV collagen. 8 ) Upregulated levels of MMP-2 have been reported in various human malignancies. [9] [10] [11] [12] [13] In addition, suppression of MMP-2 activity by synthetic or natural inhibitors has been found to inhibit tumor invasion in vitro and metastasis in vivo. 14) Hence this enzyme has been identified as crucial for the process of angiogenesis 15) and used as a target inanti-cancer therapy.
16)
The name Wnt is derived from Drosophilia segment polarity gene Wingless and mouse proto-oncogene Int-1. Wnts are secreted cysteine-rich glycoprotein ligands that can act as ligands for the Frizzled family of cell membrane receptors and active receptor-mediated signaling pathways. 17) Wnt pathways play important roles in developmental processes, cell growth and differentiation. In a previous study, the progression of colon cancer was close linked to dysregulation of the Wnt/ -catenin pathway. It was first time that Wnt/-catenin inhibitors were developed as a molecular targeted therapy. 18, 19) Under normal conditions, a lack of Wnt signals, glycogen synthase kinase-3 (GSK3-), adenomatous polyposis coli (APC) and casein kinase 1 (CK1) form a -catenin destruction complex. GSK3-can phosphorylate serine/threonine residues at the N terminus of -catenin, 20, 21) phosphorylated -catenin is recognized by a -transducin-repeat-containing protein (-TrCP), which is the E3 ligase of -catenin, promoting -catenin degradation by 26S proteasome. 22, 23) On the other hand, in the presence of Wnt signals, Wnt ligands induce the phosphorylation of Disheveled (Dvl) and prevent GSK3-dependent phosphorylation of -catenin and -catenin translocates to the nucleus and binds to T-cell factor (TCF)/lymphocyte enhancer factor (LEF) sites. The -catenin-TCF/LEF complex activates expression of the anti-apoptotic protein survivin. 24) In addition, VEGF is a target of the -catenin/ TCF complex, 25) which enhances invasion by promoting angiogenesis and metastasis.
Mutation of the Wnt/-catenin pathway is observed in many human cancers. -catenin gene mutation and nuclear accumulation in hepatocellular carcinoma (HCCs) occurred at 13-34% and 11-43% respectively. 26) Overexpression of -catenin, due to a non-functioning APC protein or to mutations that eliminate phosphorylation sites within -catenin, is associated with several human cancers, including colon carcinomas, pilomatricomas, and HCC, [27] [28] [29] [30] [31] [32] but, abnormal Wnt signaling leads to enhance resistance of chemotherapeutic drugs. [33] [34] [35] Prognostic relevance of -catenin in some cancers has been reported, and elevated -catenin levels indicate a possible adverse prognosis for cancer patients. [36] [37] [38] Inhibition of Wnt/-catenin signaling activity is an effective approach to the treatment of human cancers.
Histone acetylation and deacetylation play critical roles in modulating chromatin topology and gene transcription. 39) Deacetylation is a process mediated by histone deacetylase (HDAC), which removes the acetyl group from histone tails, resulting in histones wrapping more tightly around the DNA and interfering with gene transcriptions. HDACs are usually overexpressed in tumors compared with surrounding normal tissue and are highly correlated with poor prognosis and poor survival rates. 40) They are implicated in gene regulations, stress resistance, and tumorigenesis in HCC. 41) Thus, HDAC inhibitors (HDACi) are a novel class of anticancer treatments that can inhibit proliferation and induce the differentiation or apoptosis of tumor cells, with slight toxicity to normal cells. 42, 43) The currently accepted rationale for their anti-tumor efficacy is suppression of tumor cell proliferation, metastasis, angiogenesis, invasion, and survival with slight or no toxicity to normal cells. Thus, inhibition of histone deacetylases results in upregulation of pro-apoptotic proteins together with down-regulation of anti-apoptotic proteins thus it potentially represents an efficient tool to lead cell death.
Apicidin is a novel histone deacetylase (HDAC) inhibitor derived from a fungal metabolite. [44] [45] [46] It has been reported to have a potent broad spectrum of antiproliferative activities against various cancer cell lines. [47] [48] [49] The combination of apicidin with doxorubicin enhances the antitumor effect of doxorubicin on caspase activation and tumor growth in HCCs, 50) but, the growth-inhibitory concentrations of apicidin in HCCs were higher than MCF-7 breast, AGS gastric and HepG2 liver cancer cell lines. 19, 20) Thus, induction of side effects and chemoresistance by apicidin can be expected for HCCs treatment.
The type I insulin-like growth factor receptor (IGF-IR) and its ligand play a critical role in the regulation of cellular proliferation and apoptosis. 51 ) Upregulated expression of IGF-IR and IGF-I has been documented in many animal and human malignancies. 52) Tumor cells with functional IGF-IR might be able to increase their own growth by synthesis of endogenous IGFs. In addition, clinical studies have identified high plasma IGF-I levels as a risk factor for carcinomas. 53 ) Ligand binding to IGF-IR can trigger multiple signaling pathways such as the PI3-kinase/Akt pathway which is implicated in the transmission of cell survival signals. 54, 55) In vivo inhibition of IGF-IR or IGF-I expression by antisense RNA and IGF-I peptide analogs caused suppression of tumor cell growth, 53, 56) indicating this receptor as a target for cancer therapy. 57) In a previous study, the phosphorylation levels of IGF-IR were higher in chemoresistant cancer cells than in parental ones, 58) but, inhibition of IGF-IR restored chemosensitivity in the chemoresistant cell lines. [58] [59] [60] IGF-IR makes a significant contribution to resistance to clinical therapy. 61) In this particular study, the authors investigated the cts of the -catenin and IGF-IR/PI3K/Akt pathways on metastasis in apicidin-resistant HA22T cells.
Materials and Methods
Cell culture. HA22T cells were maintained in Dulbecco's Minimum Essential Medium (D5523, Sigma, St. Louis, Missouri) containing 10% charcoal-treated FBS (Charactrized Fetal Bovine Serum, Hyclone, Long, UT) and 1% penicillin (Invitrogen, Carlsbad, California).
Whole-cell extract. Cells were extracted in a cell lysis buffer (50 mM tris-base, 0.5 M NaCl, 1.0 mM EDTA, 1% NP40, 1% Glycerol, 1 mM -mercaptoethanol and Proteinase k inhibitor) and the extracts were clarified by centrifugation.
Lowry protein assay. Bovine serum albumin (BSA) (Sigma, St. Louis, Missouri) was used to prepare standard solutions, whose concentration was 0.1, 0.2, 0.3, 0.4 and 0.5 mg/mL, respectively. The standard solution were first reacted with alkaline cupric sulfate in the presence of tartrate (2% Na-K tartrate: 1% CuSO 4 . 5H 2 O:2% Na 2 CO 3 in 0.1 N NaOH ¼ 1:1:98) during a 30-minute incubation period at room temperature. During this incubation, a tetradentate copper complex forms from four peptide bonds and one atom of copper. Following the incubation, folin phenol reagent was added. It is believed that the color enhancement occurs when the tetradentate copper complex transfers electrons to the phosphomolybdic/phosphotungstic acid complex. After the 30-minute incubation, light absorbance at value 750 nm was determined by an ELISA reader in order to generate a standard curve. Finally, protein concentration from each whole-cell extract was determined by Lowry protein assay via using the standard curve.
Western blotting. Cultured cells were lysed with lysis buffer (250 mM sucrose, 50 mM Tris-HCl, 5 mM imidazole, 2.5 mM EDTA, 2.5 mM DTT, and 0.1% Triton X-100, pH 7.40), and the protein concentration was measured by Lowry protein assay. Briefly, an aliquot of each sample equivalent to 30 mg protein was boiled after the addition of the appropriate amount of 5Â sample buffer (5 mM EDTA, 162 mM DTT, 5% SDS, 50% glycerol, 0.5 mL bromophenol blue, and 188 mM Tris, pH 8.8). The samples were separated on 10% SDS-polyacrylamide gels (PAGE) and transferred electrophoretically onto nitrocellulose filters using the Bio-Rad electrotransfer system (Bio-Rad Laboratories, Munich, Germany). Equal transfer was verified by Ponceau staining of the membranes. Antigen-antibody complexes were visualized with HRP-coupled secondary antibodies (goat anti-mouse and goat anti-rabbit, Santa Cruz Biotechnology, Dallas, TX) and a custom-made ECL detection system (2.5 mM luminol, 0.4 mM paracoumaric acid, 10 mM Tris base, and 0.15 L H 2 O 2 , pH 8.5).
Co-immunoprecipitation assay. First, 100 mL cell lysis buffer (for co-IP) (1.5 mM MgCl 2 , 1% Triton X-100, 50 mM pH 7.6 HEPES, 1 mM EDTA, 150 mM NaCl, 10% glycerol, 1 mM NaVO 3 , 10 mM NaF, 10 mM -glycerolphosphate, 5 protease inhibitor tablets, and 50 mL DDW) per plate was added to lyse the cells, which were then scarped down and stored at À80 C overnight. The method of obtaining total protein samples was the same as Western blotting. Lowry assay was applied to determine the protein concentration of each protein sample. 500 mL co-IP buffer (1.5 mM MgCl 2 , 1% Triton X-100, 50 mM pH 7.6 HEPES, 1 mM EDTA, 150 mM NaCl, 10% glycerol, 1 mM NaVO 3 , 10 mM NaF, 10 mM -glycerolphosphate, and 500 mL DDW) was mixed with 5 mL protein G-agarose and 100 mg of each protein sample in each 1.5-mL microcentrifuge tube. Nonspecific protein binding was blocked in blocking buffer (5% milk in 1X TBS) for 1 h at room temperature. 1X TBS was used to wash off residual blocking buffer on PVDF membranes, which were then shaken in 1:1000 1
Ab solutions overnight or longer depending on protein concentration and antibody binding affinity. Then the 1 Ab TBS solutions were recycled. The PVDF membranes were washed with 1X TBS 3 times and soaked and shaken in 1:1000 2
Ab solutions for 1 h at room temperature. They then were washed with 1X TBS 3 times and protein expression was measured with Western Blotting Luminol Reagent.
Cytoplasmic and nuclear fractionations. Cell cytoplasmic and nuclear fractions were separated with extraction reagent, lysis buffer A (50 mM Tris-base, 0.5 M NaCl, 1.0 mM EDTA, 1% NP40, 1% Glycerol, 1 mM -mercaptoethanol, and proteinase K inhibitor), and lysis buffer B (50 mM Tris-base, 0.5 M NaCl, 1.0 mM EDTA, 1% glycerol, and proteinase K inhibitor). In brief, 5 Â 10 6 cells were trypsinized (0.05% trypsin/0.53 mM EDTA) and resuspended in 100 mL lysis buffer B. After 10 min of ice-cold incubation, the samples were centrifuged at 3;000 g for 10 min to pellet the nuclear protein. Then, the supernatant was stored for use as the cytoplasmic fraction, and the nuclear fraction was lysed with 100 mL of lysis buffer A.
Real-time reverse-transcription PCR (RT-PCR).
Total RNA from the cells was isolated and purified with Quick-RNAÔ MiniPrep (ZYMO RESEARCH, Irvine, CA) according to the manufacturer's protocols. One mg of total RNA from each sample was subjected to first-strand cDNA synthesis with a TaqMan reverse transcription reagent kit (Takara Biotechnology, Ohtsu, Japan) in a total volume of 50 mL. A reverse transcription reaction was done at 42 C for 65 min followed by 90 C for 5 min. The primers used in the PCR reaction were Tbx3, forward primer (5 0 -TTTCAGTGATGTTTT-AAAGAGA-GGG-3 0 ) and reverse primer (5 0 -TGATTTCCTCAAAACG-AAG-TGG-3 0 ); and MMP-2, forward primer (5 0 -ACTAGAGAAGGAC-CCG-GAGG-3 0 ) and reverse primer (5 0 -GCCTGGGAGGAGTA-CAGTCA-3 0 ). Real-time PCR amplifications were done by the LightCycler QPCR System (Roche, Mannheim, Germany) using SYBR Green PCR Master Mix. One mL of reverse transcription reaction was used for a total volume of 25 mL quantitative PCR reactions. The thermal profile for SYBR real-time PCR was 95 C for 10 min followed by 50 cycles of 95 C for 15 s and 60 C for 1 min. Data were analyzed by the comparative C t method, and were normalized by GAPDH expression in each sample. pHe7 is a gene coding for a ribosomal protein, and its mRNA is constantly transcribed during the cell cycle and is stable in growth-inhibited cells. 63) Hence it was used in RT-PCR as an internal control as in this study.
Migration assay. Cell migration was measured with Boyden chamber and a polyvinyl-pyrrolidone-free polycarbonate membrane (pore size: 8-mm) (Neuro Probes, Inc., Gaithersburg, MD). The wells of the bottom chamber were filled with 10% FBS DMEM medium. The bottom chamber was added with complete medium and then covered with a polyvinyl-pyrrolidone-free polycarbonate membrane followed by the top chamber. Each well of the top chamber was filled with serum-free medium containing cells. The Boyden chamber was incubated for 4 h at 37 C to allow possible migration of cells through the membrane into the bottom chamber. The membranes were stained with Giemsa Stain (GS-500, Sigma). Cells that migrated through the membrane were counted with a counting grid, which was fitted into the eyepiece of a phase contrast microscope.
Invasion assay. An invasion assay was performed with the Boyden chamber. The surfaces of the filter (0.8 mm pore size) were coated with 50 mg Matrigel of uniform thickness for 4 h at room temperature. The uniformity of the coating was checked by Coomassie Blue staining and low-power microscopic observation. The lower chamber was filled with 10% FBS DMEM medium. The cells re-suspended in serum-free DMEM medium onto the upper surface of the filters in the chamber. After 4-h incubation at 37 C, the filter was gently removed from the chamber. The cells on the upper surface had passed through the Matrigel and attached to the lower surface. They were fixed with methanol and stained with Giemsa stain. The cells which migrated through the membrane were counted using a counting grid, which was fitted into aeyepiece of a phase-contrast microscope.
Immunofluorescence staining assay. Cells grown in a 6-cm dish and subjected to various treatments were washed 5 times with ice-cold PBS and fixed with 4% paraformaldehyde at room temperature for 30 min. They were washed five times with ice-cold PBS and permeabilized with 0.5% Triton X-100 for 10 min at 4 C. Nonspecific binding of the fixed cells was blocked with PBS containing 2% bovine serum albumin at 37 C for 30 min, followed by incubation with primary PEA3 antibody overnight at 4 C. After washing, the cells were incubated with anti-rabbit FITC-conjugated antibody at 37 C for 1 h. After staining with the anti-rabbit antibody, fluorescence was visualized using a fluorescence microscope coupled to an image-analysis system. Two-dimensional protein gel electrophoresis. For 2D-gel electrophoretic analysis of the total protein contents of the various isolated fractions, purified organelles were mixed with a equal volumes, of 10 mM potassium phosphate-buffered isotonic (0.25 M) sucrose and sedimented by centrifugation for 15 min at 47;800 g. The pellets from the total and sedimentable fractions were dissolved in a sample buffer containing 8 M urea, 65 mM dithiothreitol, 2% (w/v) Pharmalyte (Pharmacia AB, Stockholm, Sweden) and, 0.5% (v/v) Triton X-100. Material was subjected to isoelectric focusing on linear Immobiline Dry Strips, pH 3 AE 10 (Amersham Pharmacia Biotech, Uppsala, Sweden), by means of the Pharmacia Multipor II apparatus and procedure. The protein sample was loaded in the low-pH area of the isoelectric gel strips. To facilitate comparison, 0.2 mg of protein was routinely loaded on all gels. After equilibration in 2% (w/v) SDS, the strips were placed on top of a vertical SDS/PAGE gel (10%, w/v) and subjected to electrophoresis with a Bio-Rad Protean II apparatus.
Statistical analysis. Each sample was analyzed based on results that were obtained at least 3 times, and SigmaPlot 10.0 software and the standard t-test were used to analyze the data. In all cases, differences at p < 0:05 were regarded as statistically significant, ones at p < 0:01 or p < 0:001 were considered.
Results
Wnt/-catenin signaling pathways were significantly activated in the Apicidin-R HA22T cells
To determine whether the Wnt/-catenin pathway was active in the Apicidin-R HA22T cells, we assessed the expression of the Wnt/-catenin signaling pathway at the mRNA and protein levels by RT-PCR and Western blotting respectively. At first, the Apicidin-R HA22T cells displayed no different in total -catenin protein level as compared to the parental HA22T cells, but, GSK3-was significantly suppressed in the Apicidin-R HA22T cells. In addition, Tbx3 was the downstream target of the Wnt/-catenin pathway highly activated in the Apicidin-R HA22T cells when it compared to the parental HA22T cells (Fig. 1A) . The co-immunoprecipitation results indicated that the interaction of GSK3-and -catenin was significantly inhibited in the Apicidin-R HA22T cells (Fig. 1B) . The Apicidin-R HA22T cells displayed higher -catenin nuclear accumulation and Tbx3 expression compared to the HA22T cells (Fig. 1C and D) .
The Apicidin-resistant HA22T cells showed significantly enhanced cell invasion compared to the HA22T cells
In order to further investigate whether the Apicidin-R HA22T cells had enhanced cell motility, and a cell migration and invasion assay was performed with a Boyden chamber. Although no significant migration effect observed in the Apicidin-resistant HA22T cells ( Fig. 2A) , they showed significantly enhanced cell invasion ability compared to the HA22T cells (Fig. 2) .
MMP-2 metastatic signaling was strongly upregulated in the Apicidin-R HA22T cells MMP-9 and Contactin-1 protein levels were no different, as between the Apicidin-resistant HA22T cells and the HA22T cells, but, tPA was highly increased in the Apicidin-R HA22T cells compared to the HA22T cells (Fig. 3A) . In addition, the Apicidin-R HA22T cells not only was strongly upregulated the MMP-2 protein level, but also mRNA expression compared to the HA22T cells (Fig. 3) .
The suppressor MEK/ERK/PEA3 pathway of MMP-2 was highly inhibited in Apicidin-R HA22T cells
In order to determine whether the negatively regulated MEK/ERK/PEA3 pathway of MMP-2 was influenced in the Apicidin-R HA22T cells, activation of p-Raf was observed in Apicidin-R HA22T cells. Moreover, the Apicidin-R HA22T cells inhibited p-ERK and PEA3 protein level compared to the HA22T cells (Fig. 4) . A, a migration assay was performed by seeding 1:5 Â 10 4 HA22T and Apicidin-R cells in the upper wells in serum-free medium. After 4 h of incubation, cells that migrated through the membrane were counted using a counting grid, which was fitted into eyepiece of a phase-contrast microscope. B, an invasion assay was performed by seeding 1:5 Â 10 4 HA22T and Apicidin-R cells in the upper wells of Matrigel-coated Boyden chambers in serum-free medium. After 5 h of incubation, cells that migrated through the membrane were counted using a counting grid, which was fitted into an eyepiece of a phase contrast microscope.
Ã p < 0:05, values was quantified as fold of Apicidin-R relative to the parental HA22T cell levels.
## p < 0:01 statistically significant compared with the parental HA22T cells. ÃÃ p < 0:01 statistically significantly compared with the parental HA22T cells.
Inhibition of PI3K/Akt pathway, as measured by suppression of the MAPK Signaling pathway
To determine whether Apicidin-R HA22T cells would inhibit the MAPK pathway via IGF-IR/PI3K/Akt pathway. The results showed that the Apicidin-R HA22T cells greatly inhibited PEA nuclear translocation compared to the parental HA22T cells, apicidin resistance was at least partially reversed when LY294002 was applied (Figs. 5 and 6 ). AG1024 exerted a total reversal effect on apicidin resistance in the resistant strain (Figs. 5 and 6 ).
-catenin and MMP-2 activation were mediated by the IGF-IR/PI3K/Akt pathway Confirming further that the Apicidin-R HA22T cells mediated increased metastatic ability through the IGF-IR/PI3K/Akt pathway to influence the downstream targets. The Apicidin-R HA22T cells abundantly suppressed GSK3-and PEA3 and upregulated MMP-2 compared to the HA22T cells, the Apicidin resistant effect was reversed when LY294002 and AG1024 were applied (Fig. 6 ).
Discussion
Our results confirmed that the Apicidin-R HA22T cells greatly enhanced the cell survival effect via IGF-IR/PI3K/Akt signaling pathway activation. It has been reported that the IGF-IR/PI3K/Akt signaling pathway inhibit the activity of GSK3-by phosphorylation in serine 9. [62] [63] [64] [65] Inhibition of GSK3-results in the stabilization of -catenin. Our previous study found that the mRNA level of -catenin was significantly higher in tumor areas than in non-tumor one, especially in pathological grade-III tumors. Moreover, knockdown of -catenin with antisense oligonucleotides resulted in decreased cell migration and invasion ability of HA22T cells. 66) Taken together, these results suggest thatcatenin plays a crucial role in the metastasis of HCC. Hence, we strongly suggest that Wnt/-catenin pathway A B Fig. 3 . Apicidin-R Cells Upregulated Cell Metastatic Related Proteins.
A, The Western blots were carried out with anti-MMP-9, MMP-2, tPA, contactin 1, and -actin antibodies. Expression levels were qualified relative to the expression level of -actin (as internal control), and are shown as mean expression levels for three independent experiments. Columns, mean (n ¼ 3); bars, SD. ÃÃ p < 0:01 statistically significant compared the parental HA22T cells. B, Real-time RT-PCR was used to quantify mRNA expression in the HA22T and Apicidin-R cells.
ÃÃ p < 0:01 compared the parental HA22T cells. Immunofluorescence assay was performed on HA22T cells using Anti-PEA3 antibody (1:250, green), followed by DAPI nuclear counterstaining (blue). The merging of PEA3 (green) with DAPI (blue) is also shown.
over-activation is involved in the metastatic enhancement of Apicidin-R HA22T cells.
First, we assessed whether expression of proteins were altered in the Apicidin-R HA22T cells. We found that these related to cells displayed no differences in total -catenin protein level compared to the parental HA22T cells, GSK3-was significantly suppressed in Apicidin-R HA22T cells. In addition, Tbx3 was one of the downstream targets of the Wnt/-catenin pathway, which highly activated in the Apicidin-R HA22T cells compared to the parental HA22T cells (Fig. 1A) . As we have found the GSK3-is the key mediator, promoting -catenin degradation by the 26S proteasome. 67) Thus, it is possible that the Apicidin-R HA22T cells activated Tbx3 by inhibition of -catenin degradation through GSK3-suppression. Our co-immunoprecipitation results indicate that interaction between GSK3-and -catenin was significantly inhibited in the Apicidin-R HA22T cells (Fig. 1B) . Activated -catenin translocates into the cell nucleus where it acts as a transcriptional co-regulator, binding to several partners, including lymphoid enhancer factor/T cell factor (LEF/TCF) family members, to mediate transcriptional regulation of target genes. [68] [69] [70] The Apicidin-R HA22T cells displayed higher -catenin nuclear accumulation and Tbx3 expression compared to the HA22T cells (Fig. 1C-D) . Based on all the above data, we believe that the Wnt/ -catenin signaling pathways were activated in Apicidin-R HA22T cells.
IGF-IR/PI3K Akt pathway activation has been also considered in metastasis in cancer cells. 71, 72) No migration effect was observed in Apicidin-R HA22T cells ( Fig. 2A) , cell invasion ability was significantly enhanced compared to the HA22T cells (Fig. 2B) .
MMP-2, a type-IV collagenase, is thought to play a critical role in tumor cell invasion by facilitating the degradation of basement membrane type-IV collagen. 8) This enzyme has been implicated in invasion and metastasis in diverse tumors. 73, 74) In the present study, the Apicidin-R HA22T cells not only extraordinarily upregulated MMP-2 protein levels but also mRNA expression compared to the parental HA22T cells (Fig. 3A and B) . The MMP-9 and Contactin-1 protein levels were no different between the Apicidin-Resistant HA22T cells and the parental cells (Fig. 3A) . This probably the reason the Apicidin-R HA22T cells significantly enhanced cell invasion ability, but not migration.
PI3-kinase has been identified as the major transducer of the IGF-IR signal, and its activity has been found to be critical to IGF-IR induced cell survival and transcriptional and translational regulation of protein synthesis. [75] [76] [77] [78] [79] That study found that IGF-IR activated MMP-2 promoter activity. 80) In addition, deletion of the PEA3-binding site enhanced IGF-IR mediated MMP-2 promoter activity. PEA3 was a downstream target of MAPK pathways that showed inhibition of tumorigenesis. 81, 82) As the previous findings, all these observations suggested that PEA3 is a key mediator that has a negative regulatory effect on MMP-2 synthesis. Moreover, signal transduction by IGF-IR is known to involve both the ERK and the PI3K pathway. 83, 84) Akt phosphorylated C-Raf on Ser259, resulting in C-Raf inactivation which led inhibition of the MAPK pathway. 85) The previous findings indicate that IGF-I can upregulate MMP-2 synthesis via PI3-kinase/Akt signaling and is a negative regulatory signal via C-Raf/ERK signaling. We found that activation of p-Raf Ser259 occurred in the Apicidin-R HA22T cells. Moreover, those cells inhibited p-ERK and PEA3 protein level compared to the HA22T cells (Fig. 4) .
To confirm further that the Apicidin-R HA22T cells inhibited PEA3 via the IGF-IR/PI3K/Akt signaling pathway, first we tested the effects of pharmacological inhibitors of these pathways on PEA3 expression. The Immunofluorescence staining results showed that the Apicidin-R HA22T cells greatly inhibited PEA nuclear translocation compared to the parental HA22T cells. The Apicidin resistant effect was reversed when LY294002 and AG1024 (Fig. 5) were applied. In addition, the Apicidin-R HA22T cells abundantly suppressed GSK3-and PEA3, and upregulated MMP-2 compared to the HA22T cells. The Apicidin resistant effect was at least partially reversed by LY294002 and, was totally reversed by AG1024 (Figs. 5 and 6 ).
2D gel electrophoresis technique was applied to compare the total protein levels of the HA22T and Apicidin-R HA22T cells. The results indicated that the Apicidin-R HA22T cells had highly increased protein levels of cofilin-1 (CFL1) and peroiredoxin-2 (PRDXII) as compared to the parental HA22T cells (data not shown). CFL1 is an actin-binding protein, and an essential regulator of actin dynamics, as it promotes lamellipodia formation. 88, 89) PRDXII is an antioxidant protein that has been reported to be overexpressed in various kinds of human tumors. [88] [89] [90] [91] In addition, it was one of the targets of miR-122a. 92) miR-122a is the most abundantly expressed microRNA in liver tissue, was found to be downregulation about 70% of HCCs. 93) Lost function of miR-122a was highly correlated to poor prognosis and metastasis in HCC patients. [94] [95] [96] Consistently with our former findings, the results of the 2D gel electrophoresis experiment suggested that the Apicidin-R HA22T cells had a enhanced metastatic effect compared to the parental HA22T cells.
In summary, Apicidin-R HA22T cells activate the Wnt/-catenin signaling pathway and induce MMP-2 expression via IGF-IR/PI3K/Akt signaling pathway activation enhancing cell metastatic effect (Fig. 7) . All A, the cells were treated for 24 h with 20 mM LY294002 and 1 mM AG1024 in the presence of serum (10% FBS) in the culture medium. Western blot analysis of total lysates used PEA3, MMP-2, GSK-, and -actin antibodies to detect the protein levels. Values were quantified as fold of Apicidin-R relative to parental HA22T cells levels.
the molecular evidence strongly suggests that the Apicidin-R HA22T cells enhanced cell metastasis due to activation of IGF-IR/PI3K/Akt signaling. Hence we believe novel strategies to block IGF-IR/PI3K/Akt signaling can overcome the chemoresistance and metastatic promotion caused by the HDAC inhibitor, improving the overall survival of HCC patients.
